Waples DC

Acea Biosciences, now part of Agilent, is a leading provider of flow cytometry and real-time live cell analysis solutions for researchers. With a range of innovative products such as NovoCyte flow cytometers and xCELLigence RTCA instruments, they offer transformative research solutions in areas like immunotherapy, infectious disease, and drug discovery. Agilent's cutting-edge technologies, including the NovoCyte Penteon flow cytometer and xCELLigence RTCA eSight, empower scientists to capture critical data points and conduct high-quality, high-throughput experiments with ease. By joining forces with Agilent, Acea Biosciences continues to advance scientific understanding at the cellular level, supporting customers in their research endeavors.Generated from the website

Phoenix Flow Systems, based in San Diego, CA, specializes in innovative cell technology solutions, including assay kits for apoptosis and cell proliferation analysis. The company is known for its longtime commitment to quality and customer support, offering products such as the TUNEL assay kit and MultiCycle AV DNA analysis software. With a focus on ease of use and comprehensive solutions, their products come complete with necessary reagents, positive and negative controls, and full troubleshooting support. Among their notable offerings is the EZ-BrdU kit for measuring cell proliferation and a cost-effective sheath fluid concentrate aimed at optimizing flow cytometry practices. Generated from the website

Organovo Inc, based in San Diego, California, specializes in pioneering 3D bioprinting technology for the development of human tissues aimed at enhancing drug discovery processes. The company is focused on creating innovative solutions that support pharmaceutical research and improve the efficiency of drug testing. With a commitment to advancing medical technology, Organovo's leadership team is dedicated to leveraging its cutting-edge bioprinting capabilities to transform the landscape of drug development. The company actively engages in providing updates on its business operations and financial health, ensuring transparency with stakeholders. Generated from the website